Related references
Note: Only part of the references are listed.Deficiency of pRb Family Proteins and p53 in Invasive Urothelial Tumorigenesis
Feng He et al.
CANCER RESEARCH (2009)
Inactivation of p53 and Pten promotes invasive bladder cancer
Anna M. Puzio-Kuter et al.
GENES & DEVELOPMENT (2009)
Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication
Efstathios Kastritis et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phosphatidylinositol 3-Kinase Signaling Does Not Activate the Wnt Cascade
Ser Sue Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Tenets of PTEN tumor suppression
Leonardo Salmena et al.
CELL (2008)
Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
Maximilian Burger et al.
EUROPEAN UROLOGY (2008)
Tissue-specific role of glycogen synthase kinase 3β in glucose homeostasis and insulin action
Satish Patel et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation
Victoria Marsh et al.
NATURE GENETICS (2008)
Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice
Teruaki Fujishita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular alterations associated with bladder cancer initiation and progression
Carlos Cordon-Cardo
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
Glycogen synthase kinase 3α-specific regulation of murine hepatic glycogen metabolism
Katrina MacAulay et al.
CELL METABOLISM (2007)
The soluble Wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo
Venita I. DeAlmeida et al.
CANCER RESEARCH (2007)
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis
Lan Mo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular biology of bladder cancer
Nuno M. Luis et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2007)
Understanding urothelial carcinoma through cancer pathways
Wolfgang A. Schulz
INTERNATIONAL JOURNAL OF CANCER (2006)
Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients
Hiroshi Tsuruta et al.
CANCER RESEARCH (2006)
Observer variation in immunohistochemical analysis of protein expression, time for a change?
T. Kirkegaard et al.
HISTOPATHOLOGY (2006)
The prognostic value of E-cadherin, α-, β-, and γ-catenin in urothelial cancer of the upper urinary tract
K Kashibuchi et al.
EUROPEAN UROLOGY (2006)
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ
R Namba et al.
CLINICAL CANCER RESEARCH (2006)
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner
LI Yoo et al.
CANCER RESEARCH (2006)
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Gene deletion in urothelium by specific expression of Cre recombinase
L Mo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas
S Nagayama et al.
ONCOGENE (2005)
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer
CJ Marsit et al.
CANCER RESEARCH (2005)
Role that phosphorylation of GSK3 plays in insulin
EJ McManus et al.
EMBO JOURNAL (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Urothelial tumorigenesis: A tale of divergent pathways
XR Wu
NATURE REVIEWS CANCER (2005)
Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract:: Effect of loss of β-catenin
H Ireland et al.
GASTROENTEROLOGY (2004)
WNT and β-catenin signalling:: Diseases and therapies
RT Moon et al.
NATURE REVIEWS GENETICS (2004)
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth
L You et al.
CANCER RESEARCH (2004)
Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity
R Kemp et al.
NUCLEIC ACIDS RESEARCH (2004)
β-catenin mutations correlate with over expression of c-myc and cyclin D1 genes in bladder cancer
H Shiina et al.
JOURNAL OF UROLOGY (2002)
Cre/LoxP-mediated inactivation of the murine Pten tumor suppressor gene
R Lesche et al.
GENESIS (2002)
Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation
ZT Zhang et al.
ONCOGENE (2001)
Aberrant expression of β-catenin and mutation of exon 3 of the β-catenin gene in renal and urothelial carcinomas
XD Zhu et al.
PATHOLOGY INTERNATIONAL (2000)
Linking colorectal cancer to Wnt signaling
M Bienz et al.
CELL (2000)
Share Paper
